{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:11:28Z","timestamp":1780477888352,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4755-11-78","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T04:01:14Z","timestamp":1415678474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Patients\u2019 administration preferences: progesterone vaginal insert (Endometrin\u00ae) compared to intramuscular progesterone for Luteal phase support"],"prefix":"10.1186","volume":"11","author":[{"given":"Angeline N","family":"Beltsos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Doody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice D","family":"Domar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"key":"362_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/TCRM.S4192","volume":"5","author":"JH Check","year":"2009","unstructured":"Check JH: Luteal phase support in assisted reproductive technology treatment: Focus on endometrin(r) (progesterone) vaginal insert. Ther Clin Risk Manag. 2009, 5: 403-407.","journal-title":"Ther Clin Risk Manag"},{"key":"362_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/GCO.0b013e3281338874","volume":"19","author":"AJ DiLuigi","year":"2007","unstructured":"DiLuigi AJ, Nulsen JC: Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function. Curr Opin in Obstet ynecol. 2007, 19: 258-265. 10.1097\/GCO.0b013e3281338874.","journal-title":"Curr Opin in Obstet ynecol"},{"key":"362_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.fertnstert.2008.02.012","volume":"89","author":"ASRM Practice Bulletin","year":"2008","unstructured":"ASRM Practice Bulletin: Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin. Fertil Steril. 2008, 89: 789-792.","journal-title":"Fertil Steril"},{"key":"362_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/humupd\/dmm021","volume":"13","author":"HM Fatemi","year":"2007","unstructured":"Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P: An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update. 2007, 13: 581-590. 10.1093\/humupd\/dmm021.","journal-title":"Hum Reprod Update"},{"key":"362_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1472-6483(10)61847-0","volume":"6","author":"AS Penzias","year":"2003","unstructured":"Penzias AS, Alper MM: Luteal support with vaginal micronized progesterone gel in assisted reproduction. Reprod Biomed Online. 2003, 6: 287-295. 10.1016\/S1472-6483(10)61847-0.","journal-title":"Reprod Biomed Online"},{"key":"362_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.fertnstert.2009.02.018","volume":"92","author":"PW Zarutskie","year":"2009","unstructured":"Zarutskie PW, Phillips JA: A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Fert Steril. 2009, 92: 163-169. 10.1016\/j.fertnstert.2009.02.018.","journal-title":"Fert Steril"},{"key":"362_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0015-0282(99)00362-3","volume":"72","author":"SJ Chantilis","year":"1999","unstructured":"Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD: Use of crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril. 1999, 72: 823-829. 10.1016\/S0015-0282(99)00362-3.","journal-title":"Fertil Steril"},{"key":"362_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1472-6483(10)60597-4","volume":"16","author":"L Dal Prato","year":"2008","unstructured":"Dal Prato L, Bianchi L, Cattoli M, Tarozzi N, Flamigni C, Borini A: Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial. Reprod Biomed Online. 2008, 16: 361-367. 10.1016\/S1472-6483(10)60597-4.","journal-title":"Reprod Biomed Online"},{"key":"362_CR9","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0015-0282(99)00390-8","volume":"72","author":"K Jobanputra","year":"1999","unstructured":"Jobanputra K, Toner JP, Denoncourt R, Gibbons WE: Crinone 8% (90\u00a0mg) given once daily for progesterone replacement therapy in donor egg cycles. Fertil Steril. 1999, 72: 980-984. 10.1016\/S0015-0282(99)00390-8.","journal-title":"Fertil Steril"},{"key":"362_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.fertnstert.2009.10.004","volume":"94","author":"S Kahraman","year":"2010","unstructured":"Kahraman S, Karagozoglu SH, Karlikaya G: The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial. Fertil Steril. 2010, 94: 761-763. 10.1016\/j.fertnstert.2009.10.004.","journal-title":"Fertil Steril"},{"key":"362_CR11","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.fertnstert.2008.03.072","volume":"91","author":"N Khan","year":"2009","unstructured":"Khan N, Richter KS, Newsome TL, Blake EJ, Yankov VI: Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer. Fertil Steril. 2009, 91: 2445-2450. 10.1016\/j.fertnstert.2008.03.072.","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"362_CR12","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.1016\/j.fertnstert.2008.07.457","volume":"90","author":"M Martin-Johnson","year":"2008","unstructured":"Martin-Johnson M, Beltsos A, Robinson A, Gress N, Elgar C, Byers M: Luteal phase support with endometrin vs. Progesterone in oil in in vitro fertilization cycles. Fertil Steril. 2008, 90 (Suppl): S459-","journal-title":"Fertil Steril"},{"key":"362_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.fertnstert.2009.02.047","volume":"93","author":"MF Mitwally","year":"2010","unstructured":"Mitwally MF, Diamond MP, Abuzeid M: Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2010, 93: 554-569. 10.1016\/j.fertnstert.2009.02.047.","journal-title":"Fertil Steril"},{"key":"362_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.11.018","volume":"97","author":"KM Silverberg","year":"2012","unstructured":"Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ, Minter T: Vaginal (crinone 8%) gel vs. Intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial. Fertil Steril. 2012, 97: 344-348. 10.1016\/j.fertnstert.2011.11.018.","journal-title":"Fertil Steril"},{"key":"362_CR15","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","volume":"94","author":"E Yanushpolsky","year":"2010","unstructured":"Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M: Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study. Fertil Steril. 2010, 94: 2596-2599. 10.1016\/j.fertnstert.2010.02.033.","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"362_CR16","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.fertnstert.2011.07.505","volume":"96","author":"AS Beltsos","year":"2011","unstructured":"Beltsos AS, Sanchez M, Doody K, Bush M, Scobey J: Efficacy of vaginal progesterone inserts (Endometrin) compared to intramuscular progesterone in oil (PIO) for luteal phase support in PCOS patients. Fertil Steril. 2011, 96 (Suppl): S130-","journal-title":"Fertil Steril"},{"key":"362_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.fertnstert.2012.09.019","volume":"99","author":"EC Feinberg","year":"2013","unstructured":"Feinberg EC, Beltsos AN, Nicolaou E, Marut EL, Uhler ML: Endometrin as luteal phase support in assisted reproduction. Fertil Steril. 2013, 99: 174-178. 10.1016\/j.fertnstert.2012.09.019.","journal-title":"Fertil Steril"},{"key":"362_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0015-0282(01)02872-2","volume":"76","author":"AM Propst","year":"2001","unstructured":"Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH: A randomized study comparing crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril. 2001, 76: 1144-1149. 10.1016\/S0015-0282(01)02872-2.","journal-title":"Fertil Steril"},{"key":"362_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/humrep\/15.6.1284","volume":"15","author":"WB Schoolcraft","year":"2000","unstructured":"Schoolcraft WB, Hesla JS, Gee MJ: Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum Reprod. 2000, 15: 1284-1288. 10.1093\/humrep\/15.6.1284.","journal-title":"Hum Reprod"},{"key":"362_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"EA-SPCWG Rotterdam","year":"2004","unstructured":"Rotterdam EA-SPCWG: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19: 41-47.","journal-title":"Hum Reprod"},{"key":"362_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.fertnstert.2008.01.069","volume":"91","author":"KJ Doody","year":"2009","unstructured":"Doody KJ, Schnell VL, Foulk RA, Miller CE, Kolb BA, Blake EJ, Yankov VI: Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of menopur and bravelle for controlled ovarian hyperstimulation. Fertil Steril. 2009, 91: 1012-1017. 10.1016\/j.fertnstert.2008.01.069.","journal-title":"Fertil Steril"},{"key":"362_CR22","volume-title":"Endometrin","author":"Ferring Pharmaceuticals, Inc","year":"2010","unstructured":"Ferring Pharmaceuticals, Inc: Endometrin. 2010, Parsippany, NJ, USA: Ferring Pharmaceuticals, Inc, [US package insert]"},{"key":"362_CR23","volume-title":"Crinone","author":"Watson Pharmaceuticals, Inc","year":"2011","unstructured":"Watson Pharmaceuticals, Inc: Crinone. 2011, Parsippany, NJ, USA: Watson Pharmaceuticals, Inc, [package insert]"},{"key":"362_CR24","volume-title":"Follistim","author":"Merck & Co, Inc","year":"2012","unstructured":"Merck & Co, Inc: Follistim. 2012, Kenilworth, NJ, USA: Merck & Co, Inc, [package insert]"},{"key":"362_CR25","volume-title":"Menopur","author":"Ferring Pharmaceuticals, Inc","year":"2012","unstructured":"Ferring Pharmaceuticals, Inc: Menopur. 2012, Parsippany, NJ, USA: Ferring Pharmaceuticals, Inc, [package insert]"},{"key":"362_CR26","volume-title":"Progesterone","author":"American Regent, Inc","year":"2009","unstructured":"American Regent, Inc: Progesterone. 2009, Shirley, NY, USA: American Regent, Inc, [package insert]"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4755-11-78\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-78","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:17:45Z","timestamp":1630585065000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/1742-4755-11-78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["362"],"URL":"https:\/\/doi.org\/10.1186\/1742-4755-11-78","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]},"assertion":[{"value":"4 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"78"}}